Immunogen Inc
IMGN
IMGN was delisted on the 9th of February, 2024.
192 hedge funds and large institutions have $221M invested in Immunogen Inc in 2019 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 63 increasing their positions, 53 reducing their positions, and 43 closing their positions.
187% more call options, than puts
Call options by funds: $2.47M | Put options by funds: $860K
19% more repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 53
9% less funds holding
Funds holding: 212 → 192 (-20)
31% less capital invested
Capital invested by funds: $320M → $221M (-$98.4M)
37% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 43
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$5.9M |
| 2 |
ClearBridge Investments
New York
|
+$3.77M |
| 3 |
JP Morgan Chase
New York
|
+$3.23M |
| 4 |
Millennium Management
New York
|
+$2.22M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
+$2.11M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$22.9M |
| 2 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$4.13M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$4.01M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$3.7M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$3.4M |
IMGN Hedge Fund Activity: Q2 2019 in Review
192 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q2 2019, worth a combined $221M — down 31% from $320M a quarter earlier.
Sellers outnumbered buyers: 43 funds closed out of IMGN and 27 opened new positions — a net loss of 16 holders — while 53 trimmed existing stakes and 63 added.
The largest buyer was Morgan Stanley, adding an estimated $5.9M. The largest seller was State Street, cutting an estimated $22.9M.
- 192 institutional investors held Immunogen Inc (IMGN) as of Q2 2019, down from 212 in Q1 2019.
- Funds reported $221M of Immunogen Inc stock for Q2 2019, down 31% quarter-over-quarter.
- 27 funds opened new Immunogen Inc positions in Q2 2019 and 43 closed out, a net change of -16 holders.
- The largest Immunogen Inc buyer in Q2 2019 was Morgan Stanley, an estimated $5.9M added.
- The largest Immunogen Inc seller in Q2 2019 was State Street, an estimated $22.9M sold.
Based on aggregated 13F filings for Q2 2019.